Closed

Provision of Spironolactone and Placebo for Clinical trials

University of Southampton · £80,000 – £117,000 · closes 14 Mar 2018

£80,000 – £117,000

Estimated value

Closed

Deadline

8 Feb 2018

Published

This tender has closed.

See what's open in medical equipment and pharmaceuticals, or get contracts like this in your inbox each morning — free.

Set up free alerts Open medical equipment and pharmaceuticals tenders

About this contract

The University of Southampton is looking for a company to procure, re-package, label, store & distribute a drug to 5 health care sites across England. The requirement is for use in a multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone in the treatment of moderate-severe persistent acne in adult women compared to placebo, in addition to standard treatment. The two equal arms are as follows: o Oral spironolactone 50 mg/100mg once daily for 24 weeks plus standard care o Placebo once daily for 24 weeks plus standard care Additional information: Is a Recurrent Procurement Type? : No